Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC29 Inhibitors

TTC29, or Tetratricopeptide Repeat Domain 29, is a protein encoded by the TTC29 gene. The "tetratricopeptide repeat" in its name refers to a structural motif that is frequently involved in protein-protein interactions. Proteins containing such motifs, including TTC29, typically serve as scaffolds, mediating the assembly of complex protein structures or facilitating interactions between various proteins. With this general role of TPR-containing proteins, TTC29 is likely involved in specific protein-protein interactions within the cell, aiding in the formation or regulation of multi-protein complexes.

TTC29 inhibitors would be molecules or strategies designed to impede the function, expression, or stability of the TTC29 protein. Inhibitors might disrupt the protein-protein interactions mediated by TTC29, thereby affecting the formation or function of multi-protein complexes in which TTC29 is involved. Such inhibitors could include small molecules that hinder TTC29's ability to bind to its interaction partners, antisense oligonucleotides targeting its mRNA to decrease its expression, or agents that impact its post-translational modifications, altering TTC29's stability or interaction capabilities. Investigating the effects of inhibiting TTC29 can offer insights into its specific roles within cells and deepen our understanding of the intricate network of protein interactions and complexes it may be part of.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA synthesis. This action could potentially inhibit the transcription of the TTC29 gene, leading to decreased expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide blocks eukaryotic protein synthesis. By inhibiting translation, it could reduce TTC29 protein levels.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-FU affects RNA processing and function. Its action might indirectly suppress TTC29 gene transcription or mRNA stability.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. Given PI3K's role in various cellular processes, its inhibition might indirectly downregulate TTC29 expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an MEK inhibitor. MAPK/ERK pathways could be involved in various cellular processes, and its inhibition might influence TTC29 expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid impacts cellular differentiation processes. It might influence TTC29 expression during specific developmental stages.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR signaling, potentially impacting protein synthesis and stability, which could lead to reduced TTC29 levels.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea interferes with DNA synthesis. It could potentially impact the proliferation of cells and thereby TTC29 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG has roles in modulating gene expression in certain contexts. It might indirectly influence TTC29 expression in specific cells.